Stockreport

DiaMedica Therapeutics Receives Health Canada Clearance to Initiate Phase 2 Study of DM199 in Preeclampsia

DiaMedica Therapeutics Inc.  (DMAC) 
Last diamedica therapeutics inc. earnings: 11/13 04:12 pm Check Earnings Report
PDF “No Objection Letter” from Health Canada enables initiation of Phase 2 DM199 study in early-onset preeclampsiaDM199 Preeclampsia program featured in recent National Publ [Read more]